Loading…
Determination of dihydroxymelphalan in perfusate, blood plasma, and lung tissue by HPLC-MS: Use in a pharmacokinetic study
s A rapid, sensitive, and selective method for determining dihydroxymelphalan ( DHM ) in biological samples by HPLC-MS is developed. Sample pretreatment of blood plasma, perfusate, and lung tissue includes the steps of hydrolysis, homogenization (for tissue), and protein precipitation. The recovery...
Saved in:
Published in: | Journal of analytical chemistry (New York, N.Y.) N.Y.), 2014-04, Vol.69 (4), p.377-383 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43 |
---|---|
cites | cdi_FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43 |
container_end_page | 383 |
container_issue | 4 |
container_start_page | 377 |
container_title | Journal of analytical chemistry (New York, N.Y.) |
container_volume | 69 |
creator | Sidorova, A. A. Grigoriev, A. V. Timofeeva, E. S. Levchenko, E. V. |
description | s
A rapid, sensitive, and selective method for determining dihydroxymelphalan (
DHM
) in biological samples by HPLC-MS is developed. Sample pretreatment of blood plasma, perfusate, and lung tissue includes the steps of hydrolysis, homogenization (for tissue), and protein precipitation. The recovery of DHM, is 91.2 ± 4.0, 89.5 ± 2.7, and 75.9 ± 3.8% for perfusion solution, blood plasma, and lung tissue, respectively. The detection limit for DHM is 1.0 ng/mL in perfusate and blood plasma and 2.0 ng/mL in tissue. The method was applied to the study of the pharmacokinetics of an antitumor drug Alkeran after the intraoperative isolated chemoperfusion of lung. |
doi_str_mv | 10.1134/S1061934814040108 |
format | article |
fullrecord | <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_gale_infotracmisc_A372884737</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A372884737</galeid><sourcerecordid>A372884737</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43</originalsourceid><addsrcrecordid>eNp9kU1v1DAQQCMEEqXwA7hZ4oTUtJ44Hw63agu00iIQS8_RrD1JXRJ7ZTtSw6_Hq-1lxQrNYUYz781hJsveA78EEOXVBngNrSgllLzkwOWL7AxqLnMBbfsy1Wmc7-evszchPHLOWwn1WfbnhiL5yViMxlnmeqbNw6K9e1omGncPOKJlxrId-X4OGOmCbUfnNNuNGCa8YGg1G2c7sGhCmIltF3b7Y73Kv20-sftAexdZ2uMnVO63sRSNYiHOenmbvepxDPTuOZ9n918-_1rd5uvvX-9W1-tclUUTc8RCQkO8kb2WLddEVJPgVS8qRNAF1y1gCVrWmiq-bXSlBWxVDQ2QqlQpzrMPh70DjtQZ27voUU0mqO5aNIWUZSOaROUnqIEseRydpd6k9hF_eYJPoWky6qTw8UhITKSnOOAcQne3-XnMwoFV3oXgqe923kzolw54t_9398-_k1McnJBYO5DvHt3sbbrsf6S_z7erTQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Determination of dihydroxymelphalan in perfusate, blood plasma, and lung tissue by HPLC-MS: Use in a pharmacokinetic study</title><source>Springer Link</source><creator>Sidorova, A. A. ; Grigoriev, A. V. ; Timofeeva, E. S. ; Levchenko, E. V.</creator><creatorcontrib>Sidorova, A. A. ; Grigoriev, A. V. ; Timofeeva, E. S. ; Levchenko, E. V.</creatorcontrib><description>s
A rapid, sensitive, and selective method for determining dihydroxymelphalan (
DHM
) in biological samples by HPLC-MS is developed. Sample pretreatment of blood plasma, perfusate, and lung tissue includes the steps of hydrolysis, homogenization (for tissue), and protein precipitation. The recovery of DHM, is 91.2 ± 4.0, 89.5 ± 2.7, and 75.9 ± 3.8% for perfusion solution, blood plasma, and lung tissue, respectively. The detection limit for DHM is 1.0 ng/mL in perfusate and blood plasma and 2.0 ng/mL in tissue. The method was applied to the study of the pharmacokinetics of an antitumor drug Alkeran after the intraoperative isolated chemoperfusion of lung.</description><identifier>ISSN: 1061-9348</identifier><identifier>EISSN: 1608-3199</identifier><identifier>DOI: 10.1134/S1061934814040108</identifier><language>eng</language><publisher>Moscow: Pleiades Publishing</publisher><subject>Analytical Chemistry ; Antimitotic agents ; Antineoplastic agents ; Chemical properties ; Chemistry ; Chemistry and Materials Science ; High performance liquid chromatography ; Mass spectrometry ; Pharmacokinetics ; Physiological aspects</subject><ispartof>Journal of analytical chemistry (New York, N.Y.), 2014-04, Vol.69 (4), p.377-383</ispartof><rights>Pleiades Publishing, Ltd. 2014</rights><rights>COPYRIGHT 2014 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43</citedby><cites>FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids></links><search><creatorcontrib>Sidorova, A. A.</creatorcontrib><creatorcontrib>Grigoriev, A. V.</creatorcontrib><creatorcontrib>Timofeeva, E. S.</creatorcontrib><creatorcontrib>Levchenko, E. V.</creatorcontrib><title>Determination of dihydroxymelphalan in perfusate, blood plasma, and lung tissue by HPLC-MS: Use in a pharmacokinetic study</title><title>Journal of analytical chemistry (New York, N.Y.)</title><addtitle>J Anal Chem</addtitle><description>s
A rapid, sensitive, and selective method for determining dihydroxymelphalan (
DHM
) in biological samples by HPLC-MS is developed. Sample pretreatment of blood plasma, perfusate, and lung tissue includes the steps of hydrolysis, homogenization (for tissue), and protein precipitation. The recovery of DHM, is 91.2 ± 4.0, 89.5 ± 2.7, and 75.9 ± 3.8% for perfusion solution, blood plasma, and lung tissue, respectively. The detection limit for DHM is 1.0 ng/mL in perfusate and blood plasma and 2.0 ng/mL in tissue. The method was applied to the study of the pharmacokinetics of an antitumor drug Alkeran after the intraoperative isolated chemoperfusion of lung.</description><subject>Analytical Chemistry</subject><subject>Antimitotic agents</subject><subject>Antineoplastic agents</subject><subject>Chemical properties</subject><subject>Chemistry</subject><subject>Chemistry and Materials Science</subject><subject>High performance liquid chromatography</subject><subject>Mass spectrometry</subject><subject>Pharmacokinetics</subject><subject>Physiological aspects</subject><issn>1061-9348</issn><issn>1608-3199</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kU1v1DAQQCMEEqXwA7hZ4oTUtJ44Hw63agu00iIQS8_RrD1JXRJ7ZTtSw6_Hq-1lxQrNYUYz781hJsveA78EEOXVBngNrSgllLzkwOWL7AxqLnMBbfsy1Wmc7-evszchPHLOWwn1WfbnhiL5yViMxlnmeqbNw6K9e1omGncPOKJlxrId-X4OGOmCbUfnNNuNGCa8YGg1G2c7sGhCmIltF3b7Y73Kv20-sftAexdZ2uMnVO63sRSNYiHOenmbvepxDPTuOZ9n918-_1rd5uvvX-9W1-tclUUTc8RCQkO8kb2WLddEVJPgVS8qRNAF1y1gCVrWmiq-bXSlBWxVDQ2QqlQpzrMPh70DjtQZ27voUU0mqO5aNIWUZSOaROUnqIEseRydpd6k9hF_eYJPoWky6qTw8UhITKSnOOAcQne3-XnMwoFV3oXgqe923kzolw54t_9398-_k1McnJBYO5DvHt3sbbrsf6S_z7erTQ</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>Sidorova, A. A.</creator><creator>Grigoriev, A. V.</creator><creator>Timofeeva, E. S.</creator><creator>Levchenko, E. V.</creator><general>Pleiades Publishing</general><general>Springer</general><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope></search><sort><creationdate>20140401</creationdate><title>Determination of dihydroxymelphalan in perfusate, blood plasma, and lung tissue by HPLC-MS: Use in a pharmacokinetic study</title><author>Sidorova, A. A. ; Grigoriev, A. V. ; Timofeeva, E. S. ; Levchenko, E. V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Analytical Chemistry</topic><topic>Antimitotic agents</topic><topic>Antineoplastic agents</topic><topic>Chemical properties</topic><topic>Chemistry</topic><topic>Chemistry and Materials Science</topic><topic>High performance liquid chromatography</topic><topic>Mass spectrometry</topic><topic>Pharmacokinetics</topic><topic>Physiological aspects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sidorova, A. A.</creatorcontrib><creatorcontrib>Grigoriev, A. V.</creatorcontrib><creatorcontrib>Timofeeva, E. S.</creatorcontrib><creatorcontrib>Levchenko, E. V.</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Science</collection><jtitle>Journal of analytical chemistry (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sidorova, A. A.</au><au>Grigoriev, A. V.</au><au>Timofeeva, E. S.</au><au>Levchenko, E. V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determination of dihydroxymelphalan in perfusate, blood plasma, and lung tissue by HPLC-MS: Use in a pharmacokinetic study</atitle><jtitle>Journal of analytical chemistry (New York, N.Y.)</jtitle><stitle>J Anal Chem</stitle><date>2014-04-01</date><risdate>2014</risdate><volume>69</volume><issue>4</issue><spage>377</spage><epage>383</epage><pages>377-383</pages><issn>1061-9348</issn><eissn>1608-3199</eissn><abstract>s
A rapid, sensitive, and selective method for determining dihydroxymelphalan (
DHM
) in biological samples by HPLC-MS is developed. Sample pretreatment of blood plasma, perfusate, and lung tissue includes the steps of hydrolysis, homogenization (for tissue), and protein precipitation. The recovery of DHM, is 91.2 ± 4.0, 89.5 ± 2.7, and 75.9 ± 3.8% for perfusion solution, blood plasma, and lung tissue, respectively. The detection limit for DHM is 1.0 ng/mL in perfusate and blood plasma and 2.0 ng/mL in tissue. The method was applied to the study of the pharmacokinetics of an antitumor drug Alkeran after the intraoperative isolated chemoperfusion of lung.</abstract><cop>Moscow</cop><pub>Pleiades Publishing</pub><doi>10.1134/S1061934814040108</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1061-9348 |
ispartof | Journal of analytical chemistry (New York, N.Y.), 2014-04, Vol.69 (4), p.377-383 |
issn | 1061-9348 1608-3199 |
language | eng |
recordid | cdi_gale_infotracmisc_A372884737 |
source | Springer Link |
subjects | Analytical Chemistry Antimitotic agents Antineoplastic agents Chemical properties Chemistry Chemistry and Materials Science High performance liquid chromatography Mass spectrometry Pharmacokinetics Physiological aspects |
title | Determination of dihydroxymelphalan in perfusate, blood plasma, and lung tissue by HPLC-MS: Use in a pharmacokinetic study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A42%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determination%20of%20dihydroxymelphalan%20in%20perfusate,%20blood%20plasma,%20and%20lung%20tissue%20by%20HPLC-MS:%20Use%20in%20a%20pharmacokinetic%20study&rft.jtitle=Journal%20of%20analytical%20chemistry%20(New%20York,%20N.Y.)&rft.au=Sidorova,%20A.%20A.&rft.date=2014-04-01&rft.volume=69&rft.issue=4&rft.spage=377&rft.epage=383&rft.pages=377-383&rft.issn=1061-9348&rft.eissn=1608-3199&rft_id=info:doi/10.1134/S1061934814040108&rft_dat=%3Cgale_cross%3EA372884737%3C/gale_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c427t-aa2817e078fd890deee6e305f35aa1d20d91a41d86de50b7d5d31bc6171ec5c43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A372884737&rfr_iscdi=true |